At the American Society of Nephrology (ASN) Kidney Week meeting, an interim analysis of a phase III trial of sibeprenlimab in immunoglobulin A (IgA) nephropathy showed a nearly 50% reduction in ...

At first, it just seemed like a post-pandemic hangover: scattered patients drifting into Yorkshire clinics with damaged lungs ...

Of all the ways our immune system can run amok and damage the body instead of protecting it, autoimmune encephalitis is one ...

Biomarker testing for 11 oncogenes at diagnosis enables personalized lung cancer treatment, moving away from a ...

Scientists from UMC Utrecht and their international partners have discovered two new antibodies that may lead to safer ...

Cancer research, drug safety testing and aging biology may all gain a major boost from a new fluorescent sensor developed at ...

An international research group directed by UMC Utrecht has developed and characterized two first-in-class antibodies that ...

Survival rarely comes easy when pancreatic ductal adenocarcinoma strikes. Most people learn of it only after it has spread, ...

Patients with SSc who tested positive for aPLs had a higher prevalence of unprovoked DVT/PE compared with aPL-negative patients.